CXCL9 and autoimmune disease: CXCL9, CXCL10, CXCL11, and their receptor CXCR3 are associated with the pathogenesis of several autoimmune diseases, including organ‐specific autoimmune diseases like type‐1 diabetes, hyperthyroidism, Graves' disease, as well as systemic autoimmune diseases such as rheumatoid arthritis, SLE, multiple sclerosis, and Sjögren's syndrome.10, 11, 12